|
|
Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
 Patrick Chassaigne,
Director, Late Phase Solutions Medidata, United States of America As Director of Late Phase Solutions, Patrick assists global pharmaceutical, biotechnology and medical device companies utilize electronic data capture technology to address the challenges of post-approval studies. Prior to joining Medidata, Patrick founded Chassaigne & Associates, a management consulting company with a focus on increasing operational efficiency in life sciences and technology organizations. As an independent consultant, Patrick worked with Canadian and European companies and agencies to increase their collaboration with life sciences companies in the US. In addition, Patrick held the position of Director of Life Sciences at Compaq Computer Corporation (now HP), where he was responsible for defining the overall strategy for the company�s life sciences group by identifying customer requirements for discovery, pre-clinical, clinical and sales and marketing segments. To position Compaq as a strategic partner, he designed and managed a $100 million investment program to take equity in early-stage life sciences companies. Patrick is a frequent presenter at global industry events including CBI's Registries and Post Approval Congress and DIA�s events. He holds an M.S. in Chemistry from Rensselaer Polytechnic Institute, in Troy, NY, and an M.S. in Chemical Engineering from L�Ecole Nationale Superieure de Chimie, Toulouse, France.Appearing: Day One - Wednesday 2 December 2009 13.45 Powering post-marketing studies with electronic data captureThis session will showcase best practices to implement EDC in post-marketing studies so that sponsors can reap valuable results, including increased site satisfaction and retention, better access to real-time data for analysis and improved decision making. Several case studies will also be presented to illustrate some key benefits obtained through the use of EDC. Director, Late Phase Solutions,
Medidata, United States of America |
|
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
|
|
|
|
|
